New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
TSS recently appointed of Evan Hahn as VP of North America to lead expansion in the strategic US life sciences market.

TSS expands US operations

Evan brings extensive expertise and over 20 years of experience applying innovative approaches to life sciences through a combination of technology and sophisticated applications of data, driving insights and efficiency in clinical development.

Before joining TSS, Evan led the growth of Medidata’s Randomization and Trial Supply software solution (RTSM) from product startup to an industry leader. At Cytel, he promoted the adoption of adaptive trial designs and drug supply forecasting. Across both organizations, he met with 100s of supply chain leaders globally, gaining broad insights into the challenges they face, receiving feedback from large pharma, startup biotechs, CROs, and regulatory agencies such as the FDA and NCI on biopharma supply challenges.

Evan explains the reason for his move to TSS: “Temperature monitoring plays a vital role in the drugs delivery cycle – and TSS is at the cutting edge of ensuring the delivery of safe and sustainable therapies to patients. I’m passionately committed to bringing innovative approaches to developing and delivering treatments and see tremendous opportunities to harness supply chain data into actionable insights – opportunities that are currently under-realized within biopharma.”

TSS’s technology-agnostic cloud platform is a ‘best in class’ solution that enables companies to transform their supply chain, by allowing for the ingestion and aggregation of data from disparate sources across that chain, providing end-to-end visibility and enabling direct to patient clinical trials while ensuring patient safety. Through advanced analytics and visualization of data we let users proactively address issues before they occur. With our Clinical Module, TSS is uniquely positioned to automate manual temperature excursion handling processes, and as such reduce burden for clinical sites and sponsor companies, while contributing to corporate sustainability goals.

For further information, please contact Matias Rodriguez, Head of Marketing. matias.rodriguez@tss.se

You may also be interested in

The year in review: TSS’s most-read blog articles of 2021

As 2021 draws to a close, we’ve rounded up the most-read stories we’ve published on our blog in the past 12 months – featuring automation, new technologies, data, clinical supply, and pharma logistics.
Read moreDownload Whitepaper
A futuristic, digital illustration of a pipette adding a drop of liquid to test tubes, representing advanced technology in clinical trial management.

Boost value in clinical trial management with two-way integrations

Two-way integrations between IRT and the temperature system unlock cold chain consistency in clinical development – protecting patients, maximizing value and minimizing operational costs.
Read moreDownload Whitepaper
A stethoscope resting on documents with overlaid data graphs, representing the Clinical Trial Supply East Coast event.

We are back at Clinical Trial Supply East Coast

We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.